Last reviewed · How we verify
Prednisolone 21-All-Trans-Farnesylate (prednisolone farnesylate)
Prednisolone 21-All-Trans-Farnesylate (generic name: prednisolone farnesylate) is a Corticosteroid drug. It is currently in unknown development.
Prednisolone farnesylate works by attaching to specific receptors in the body to reduce inflammation and suppress the immune system.
Prednisolone 21-All-Trans-Farnesylate is a small molecule that acts as a glucocorticoid receptor agonist. It belongs to the drug class of glucocorticoid receptor agonists.
At a glance
| Generic name | prednisolone farnesylate |
|---|---|
| Drug class | Corticosteroid |
| Therapeutic area | Immunology |
| Phase | unknown |
Mechanism of action
Imagine your body's immune system as a fire alarm that sounds when it detects an intruder. Prednisolone farnesylate is like a fire alarm silencer that reduces the alarm's sensitivity, allowing the fire department (your body's natural response) to respond more calmly and reducing the risk of damage.
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Prednisolone 21-All-Trans-Farnesylate CI brief — competitive landscape report
- Prednisolone 21-All-Trans-Farnesylate updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about Prednisolone 21-All-Trans-Farnesylate
What is Prednisolone 21-All-Trans-Farnesylate?
How does Prednisolone 21-All-Trans-Farnesylate work?
What is the generic name of Prednisolone 21-All-Trans-Farnesylate?
What drug class is Prednisolone 21-All-Trans-Farnesylate in?
What development phase is Prednisolone 21-All-Trans-Farnesylate in?
Related
- Drug class: All Corticosteroid drugs
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Immunology
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing